Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival--a 5- and 10-year follow-up.
Ynares
C
C
Division of Transplant Nephrology and Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232-5356.
Johnson
H K
HK
Kerlin
T
T
Crowe
D
D
MacDonell
R
R
Richie
R
R
D002102:Cadaver; D005190:Family; D005500:Follow-Up Studies; D006085:Graft Survival / Q000502:physiology*; D016174:Hepacivirus; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000097:blood / Q000175:diagnosis*; D018937:Hepatitis C Antibodies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000502:physiology*; D008111:Liver Function Tests; D013997:Time Factors; D014019:Tissue Donors
D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies